MAG
NXTM

Millrace Asset Group’s NxStage Medical Inc. NXTM Stock Holding History

Millrace Asset Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-38,602
Closed -$551K – 64
2015
Q2 		$551K Sell
38,602
-32,965
-46% -$558K 0.58% 52
2015
Q1 		$1.24M Buy
71,567
+50,289
+236% +$889K 1.37% 39
2014
Q4 		$382K Buy
+21,278
New +$343K 0.4% 52

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Millrace Asset Group's NXTM Position: Q3 2015 in Review

Millrace Asset Group sold out of NxStage Medical Inc. (NXTM) in Q3 2015, closing a stake of 38,602 shares — an estimated $551K sold.

Millrace Asset Group first reported a position in NXTM in Q4 2014 and held it in 3 quarters. The position peaked at $1.24M in Q1 2015. 127 funds tracked by Wall St. Rank hold NXTM as of Q3 2015.

  • Millrace Asset Group reported no remaining NxStage Medical Inc. position as of Q3 2015 after selling out during the quarter.
  • Millrace Asset Group sold 38,602 NxStage Medical Inc. shares in Q3 2015, an estimated $551K.
  • Millrace Asset Group first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 3 quarters.
  • Millrace Asset Group's NxStage Medical Inc. position peaked at $1.24M in Q1 2015.
  • 127 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2015.

Based on Millrace Asset Group's 13F filing for Q3 2015, filed 16 Nov 2015.